Roivant Sciences Ltd. · NASDAQ:ROIV
Gline Matthew reported 7 trades in Roivant Sciences Ltd. shares (Form 4)
Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026
From Nov 10 to Nov 12, 2026, Gline Matthew (Director, CEO) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.01 for US$6.41M, leaving 16,391,229 shares. Filed Nov 12, 2026 (Form 4).
- Shares
- 156,307 shares
- Price
- US$41.01 average (US$40.36 to US$42.01)
- Value
- US$6.41M
- Holding after
- 16,391,229 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Shares | Other | 25,841 | US$40.43 | 16,523,295 | Direct |
| Nov 10, 2026 | Common Shares | Other | 32,490 | US$41.13 | 16,490,805 | Direct |
| Nov 11, 2026 | Common Shares | Other | 30,083 | US$41.63 | 16,460,722 | Direct |
| Nov 11, 2026 | Common Shares | Other | 18,905 | US$42.01 | 16,441,817 | Direct |
| Nov 12, 2026 | Common Shares | Other | 41,179 | US$40.36 | 16,400,638 | Direct |
| Nov 12, 2026 | Common Shares | Other | 7,809 | US$41.13 | 16,392,829 | Direct |
| Nov 12, 2026 | Common Shares | Shares withheld for tax | 1,600 | US$41.85 | 16,391,229 | Direct |
Source
Download original · View original at SEC
Related
- Roivant Sciences Ltd.
- Gline Matthew
- Roivant Sciences Ltd. shareholders
- Form 4 · Gline Matthew · Oct 20, 2026
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Gline Matthew · Jul 2, 2026
- Form 4 · Gline Matthew · Apr 20, 2026
- Form 4 · Gline Matthew · Apr 1, 2026
- Form 4 · Gold Daniel Allen · Nov 18, 2026
- Form 4 · QVT Financial LP · Nov 18, 2026
- Form 4 · Manchester Keith S · Nov 18, 2026
- Form 4 · Sukhatme Mayukh · Nov 12, 2026
- Form 4 · Torti Frank · Nov 12, 2026